SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Chemo Pharma Labs - Quaterly Results

27 Jan 2025 Evaluate
The revenue slipped marginally during the December 2024 quarter. A decline of about Rs. 0.00 millions was observed as compared to Rs. 0.00 millions during the corresponding quarter last year.The Net Loss for the quarter ended December 2024 is Rs. -1.74 millions as compared to Net Profit of Rs. 6.77 millions of corresponding quarter ended December 2023Operating profit Margin for the quarter ended December 2024 slipped to -1.73% as compared to 6.79% of corresponding quarter ended December 2023


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202412 202312 % Var 202412 202312 % Var 202403 202303 % Var
Sales 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other Income -1.49 7.02 -121.23 7.84 15.91 -50.72 18.38 2.95 523.05
PBIDT -1.73 6.79 -125.48 6.88 14.99 -54.10 16.52 0.86 1820.93
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBDT -1.73 6.79 -125.48 6.88 14.99 -54.10 16.52 0.86 1820.93
Depreciation 0.01 0.02 -50.00 0.03 0.06 -50.00 0.08 0.13 -38.46
PBT -1.74 6.77 -125.70 6.85 14.93 -54.12 16.44 0.73 2152.05
TAX 0.00 0.00 0.00 0.00 0.00 0.00 4.43 0.26 1603.85
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 1.69 -1.04 -262.50
PAT -1.74 6.77 -125.70 6.85 14.93 -54.12 12.01 0.47 2455.32
Equity 15.00 15.00 0.00 15.00 15.00 0.00 15.00 15.00 0.00
PBIDTM(%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Starsource Multitrad Share Price

122.60 4.55 (3.85%)
16-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1693.15
Dr. Reddys Lab 1221.25
Cipla 1230.75
Zydus Lifesciences 939.20
Lupin 2326.50
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×